The Rant
Embolic Protection Devices Market Size, Key Player Revenue, SWOT, PEST & Porter’s Analysis
Submitted by aishu » Wed 04-Oct-2023, 17:45Subject Area: Design | 0 member ratings |
 |
The study on the Global Embolic Protection Devices Market is the latest report covering the impact analysis of the currently ongoing COVID-19 pandemic. The pandemic has directly affected the market by causing disruptions in the global supply chains and indirectly by inducing financial difficulties. The report offers an accurate forecast estimation of the Embolic Protection Devices industry based on the recent technological and research advancements. It also offers valuable data to assist the investors in formulating strategic business investment plans and capitalize on the emerging growth prospects in the Embolic Protection Devices market.
The embolic protection devices market plays a crucial role in preventing complications during cardiovascular procedures by capturing and removing embolic debris that may dislodge during the procedure. These devices are used in interventions such as transcatheter aortic valve replacement (TAVR), carotid artery stenting, and percutaneous coronary intervention (PCI). The global embolic protection devices market size was USD 558.0 Million in 2022 and is expected to register a revenue CAGR of 8.3% during the forecast period. The market for embolic protection devices is driven by several factors, including the increasing prevalence of cardiovascular diseases, technological advancements, and the growing adoption of minimally invasive procedures.
The rising prevalence of cardiovascular diseases is a major driver for the embolic protection devices market. According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of death globally, accounting for approximately 17.9 million deaths each year. Embolic protection devices help reduce the risk of complications, such as stroke and myocardial infarction, during cardiovascular interventions, improving patient outcomes and reducing healthcare costs.
Technological advancements in embolic protection devices have also contributed to market growth. Manufacturers are continuously innovating to develop devices with improved capture efficiency, ease of use, and compatibility with various procedures. For example, the development of distal filter devices and proximal occlusion devices has enhanced the effectiveness of embolic protection during TAVR and carotid artery stenting procedures.
However, there are certain restraints that may hinder the growth of the embolic protection devices market. One of the major challenges is the high cost associated with these devices. The initial investment, as well as the cost of disposable components, can be significant, particularly for healthcare facilities with limited budgets. This can limit the adoption of embolic protection devices, especially in developing regions.
Another challenge is the lack of reimbursement coverage for these devices in some healthcare systems. Reimbursement policies vary across countries, and the lack of adequate reimbursement can impact the affordability and accessibility of embolic protection devices. Efforts are being made to address this issue and expand reimbursement coverage for these devices.
To provide some statistics, according to a report by the American Heart Association, in the United States, cardiovascular diseases accounted for approximately 836,546 deaths in 2020, representing 1 in 3 deaths. The report also highlights the increasing adoption of minimally invasive procedures, such as TAVR and carotid artery stenting, which require the use of embolic protection devices. [Source: American Heart Association]
In terms of recent product launches, here are a few examples:
In February 2023, Boston Scientific launched the Sentinel Cerebral Protection System, an embolic protection device designed for use during TAVR procedures. The device captures and removes embolic debris that may be released during the procedure, reducing the risk of stroke.
In March 2023, Medtronic introduced the Emboshield NAV6 Embolic Protection System, a device used during carotid artery stenting procedures. The device is designed to capture and remove embolic debris, reducing the risk of stroke and improving patient outcomes.
The Global Embolic Protection Devices Market report presents comprehensive information covering insightful data for businesses and investors for the time period of . The report studies the historical data of the Embolic Protection Devices market and offers valuable information about the key segments and sub-segments, revenue generation, demand and supply scenario, trends, and other vital aspects.
To receive a free sample of the report, visit @ https://www.emergenresearch.com/request-sample/1987
Market Dynamics:
The report offers insightful information about the market dynamics of the Embolic Protection Devices market. It offers SWOT analysis, PESTEL analysis, and Porter’s Five Forces analysis to present a better understanding of the Embolic Protection Devices market, competitive landscape, factors affecting it, and to predict the growth of the industry. It also offers the impact of various market factors along with the effects of the regulatory framework on the growth of the Embolic Protection Devices market.
Embolic Protection Devices Market Segmentation:
Product Outlook (Revenue, USD Million; 2019-2032)
Distal Filter Devices
Occlusion Devices
Proximal Occlusion Filters Devices
Material Outlook (Revenue, USD Million; 2019-2032)
Nitinol
Polyurethane
Application Outlook (Revenue, USD Million; 2019-2032)
Cardio-vascular diseases
Neurovascular diseases
Peripheral vascular diseases
Coronary artery disease
Others
Competitive Landscape:
Furthermore, the report includes an in-depth analysis of the competitive landscape. The segment covers a comprehensive overview of the company profiles along with product profiles, production capacities, products/services, pricing analysis, profit margins, and manufacturing process developments. The report also covers strategic business measures undertaken by the companies to gain substantial market share. The report provides insightful information about recent mergers and acquisitions, product launches, collaborations, joint ventures, partnerships, agreements, and government deals.
The report also discusses the key players involved in the market such as
Medtronic, Boston Scientific Corporation, Abbott, Allium Ltd, Contego Medical, Inc., Edwards Lifesciences Corporation., Innovative Cardiovascular Solutions, LLC., NIPRO, Hologic, Inc., Cardinal Health.
Request a discount on the report @ https://www.emergenresearch.com/request-discount/1987
Key Reasons to Buy This Report:
The report presents a thorough examination of the Embolic Protection Devices market, elaborating on its core segments. The report conducts historical and future assessments of the market dynamics and offers precise data in a well-organized order.
The report evaluates the most prominent market growth potentials, dynamic market trends, driving factors, restraints, investment opportunities, and threats.
The report is inclusive of an in-depth study of the industry variables, manufacturers’ value chain, sales volume, market share, competitive landscape, and effective business tactics.
The report further identifies the key regions and segments dominating the market. These regions are foreseen to register fast-paced growth over the forecast duration.
Regional Landscape section of the Embolic Protection Devices report offers deeper insights into the regulatory framework, current and emerging market trends, production and consumption patterns, supply and demand dynamics, import/export, and presence of major players in each region.
Major Geographies Analyzed in the Report:
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia
0 Comments
